Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
posted on
Apr 01, 2020 12:31PM
golf ... that's my thinking also. Firstly, both Eastern and Hepa, would like to "GET" an ROI on their investment. Secondly, they would like to get as much as possible, without further risk, if possible. In the surest way. Everyone wants the best ROI they can get, but nobody wants to lose their capital either. What's the surest way?
If Eastern or Hepa want to get in the way, or utilize their leverage to maximize their opportunities, fine. Let's hear their thoughts. If they have better plan, let's hear that also.
I highly doubt either of them want to add further risk to their ivested capital, or look for ways to chase away an opportunity for a sooner ROI, or just minimize their opportunity by souring a potential deal?
Gotta figure Eastern is all about cash ROI? Hepa otoh, may negotiate for Asia/Africa rights, which would likely impact the "potential" purchase valuations to some extent?
Again, all guess work, and just an exercise for discussion and entertainment.
glta